Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2022 Earnings Call Transcript

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2022 Earnings Call Transcript November 8, 2022

Atara Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.78.

Operator: Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation....